Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer

SAN DIEGO & LOS ANGELES–(BUSINESS WIRE)—- $CLDI #immunotherapy–Calidi Biotherapeutics and City of Hope Announce Funding from CIRM to Advance CLD-101 (NeuroNova) in Ovarian Cancer
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks